Location History:
- Xizhi, TW (2010)
- New Taipei, TW (2016 - 2020)
- Taipei, TW (2019 - 2024)
Company Filing History:
5 out of 96 
3 out of 16 
3 out of 181 
Years Active: 2010-2024
Title: Chao-Yang Huang: Innovator in Antibody Research
Introduction
Chao-Yang Huang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 8 patents to his name, Huang's work has the potential to impact various medical treatments.
Latest Patents
Huang's latest patents include groundbreaking research on humanized anti-human neurotensin receptor 1 antibodies and their applications. This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases related to NTSR1 activity and signaling, as well as a method or kit for detecting NTSR1 in a sample. Another notable patent involves antibody-drug conjugates containing an anti-mesothelin antibody. This disclosure provides an immunoconjugate that includes an antibody with an antigen-binding fragment that specifically binds to an epitope in mesothelin, along with a linker and payloads for cancer treatment.
Career Highlights
Throughout his career, Chao-Yang Huang has worked with various organizations, including the Development Center for Biotechnology and DCB-USA LLC. His expertise in antibody research has positioned him as a key figure in the biotechnology sector.
Collaborations
Huang has collaborated with notable colleagues such as Jiann-Shiun Lai and Ying-Yung Lok. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Chao-Yang Huang's innovative work in antibody research and his numerous patents highlight his significant contributions to biotechnology. His ongoing research continues to pave the way for advancements in medical treatments.